2012-10-10 21:43:25 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research
Global Market Direct's pharmaceuticals report, "Santhera Pharmaceuticals Holding AG - Product Pipeline Review - 2012" provides data on the Santhera Pharmaceuticals Holding AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Santhera Pharmaceuticals Holding AG's corporate website, SEC filings, investor presentations and featured press releases, both from Santhera Pharmaceuticals Holding AG and industry-specific third party sources, put together by Global Markets Direct's team.
* Santhera Pharmaceuticals Holding AG - Brief Santhera Pharmaceuticals Holding AG overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Santhera Pharmaceuticals Holding AG human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Santhera Pharmaceuticals Holding AG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Santhera Pharmaceuticals Holding AG's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.
Full Report Details at
- www.fastmr.com/prod/468655_santhera_pharmaceuticals_holding_ag_p ..
Reasons to buy
* Evaluate Santhera Pharmaceuticals Holding AG's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Santhera Pharmaceuticals Holding AG in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Santhera Pharmaceuticals Holding AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Santhera Pharmaceuticals Holding AG.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Santhera Pharmaceuticals Holding AG and identify potential opportunities in those areas.
Partial Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
Santhera Pharmaceuticals Holding AG Snapshot
Santhera Pharmaceuticals Holding AG Overview
Santhera Pharmaceuticals Holding AG - Research and Development Overview
Key Therapeutic Areas
Santhera Pharmaceuticals Holding AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Santhera Pharmaceuticals Holding AG - Pipeline Products Glance
Santhera Pharmaceuticals Holding AG - Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Santhera Pharmaceuticals Holding AG Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Santhera Pharmaceuticals Holding AG - Drug Profiles
Mechanism of Action
Mechanism of Action
Mechanism of Action
Santhera Pharmaceuticals Holding AG - Pipeline Products by Route of Administration
Santhera Pharmaceuticals Holding AG - Pipeline Products By Mechanism of Action
Santhera Pharmaceuticals Holding AG - Recent Pipeline Updates
Santhera Pharmaceuticals Holding AG - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Santhera Pharmaceuticals Holding AG - Company Statement
Santhera Pharmaceuticals Holding AG - Locations And Subsidiaries
Other Locations & Subsidiaries
Santhera Pharmaceuticals Holding AG, Recent Developments
Santhera Pharmaceuticals Holding AG- Press Release
Apr 11, 2012: Santhera Pharma Joins EU-funded EndoStem Consortium In Preparation For Clinical Study With Omigapil In Congenital Muscular Dystrophies
Sep 02, 2009: Initiation Of Pivotal Phase III Study With Catena (Idebenone) in Duchenne Muscular Dystrophy By Santhera
Aug 03, 2009: Santhera Enrolls Last Patient in RHODOS Study Evaluating Catena In Leber's Hereditary Optic Neuropathy
Jun 30, 2009: Santhera's FJORD Phase IIb Study Demonstrates Efficacy Of JP-1730/Fipamezole For The Treatment Of Dyskinesia In Parkinson's Disease
Jun 26, 2009: Santhera Enters Agreement With Columbia University To Investigate Additional Potential of Idebenone (Catena) In MELAS
Jun 24, 2009: Santhera Partners With NIH To Evaluate Catena In Primary Progressive Multiple Sclerosis
May 19, 2009: Santhera's US Phase III IONIA Trial In Friedreich's Ataxia Misses Primary Endpoint
Apr 22, 2009: Santhera Enrolls Last Patient In Phase IIb FJORD Study With JP-1730/Fipamezole In Dyskinesia In Parkinson's Disease
Financial Deals Landscape
Santhera Pharmaceuticals Holding AG, Deals Summary
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deal Details
Santhera Pharma Secures $12.7 Million In Series C Financing
Santhera Completes Management Buyout Of Graffinity Technology Business Unit
Takeda Pharma Expands Co-Marketing Agreement With Santhera
Santhera Pharma Enters Into Co-Development Agreement With Oy Juvantia
Full Table of Contents is available at:
About Global Markets Direct
Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.